Patterns of Referral and Postdischarge Utilization of Cardiac Rehabilitation Among Patients Hospitalized With Heart Failure: An Analysis From the GWTG-HF Registry.


Journal

Circulation. Heart failure
ISSN: 1941-3297
Titre abrégé: Circ Heart Fail
Pays: United States
ID NLM: 101479941

Informations de publication

Date de publication:
08 2023
Historique:
medline: 17 8 2023
pubmed: 11 7 2023
entrez: 11 7 2023
Statut: ppublish

Résumé

Coverage for cardiac rehabilitation (CR) for patients with heart failure with reduced ejection fraction was expanded in 2014, but contemporary referral and participation rates remain unknown. Patients hospitalized for heart failure with reduced ejection fraction (≤35%) in the American Heart Association Get With The Guidelines-Heart Failure registry from 2010 to 2020 were included, and CR referral status was described as yes, no, or not captured. Temporal trends in CR referral were assessed in the overall cohort. Patient and hospital-level predictors of CR referral were assessed using multivariable-adjusted logistic regression models. Additionally, CR referral and proportional utilization of CR within 1-year of referral were evaluated among patients aged >65 years with available Medicare administrative claims data who were clinically stable for 6-weeks postdischarge. Finally, the association of CR referral with the risk of 1-year death and readmission was evaluated using multivariable-adjusted Cox models. Of 69,441 patients with heart failure with reduced ejection fraction who were eligible for CR (median age 67 years; 33% women; 30% Black), 17,076 (24.6%) were referred to CR, and referral rates increased from 8.1% in 2010 to 24.1% in 2020 ( CR referral rates have increased from 2010 to 2020. However, only 1 in 4 patients are referred to CR. Among eligible patients who received CR referral, participation was low, with <1 of 20 participating in CR.

Sections du résumé

BACKGROUND
Coverage for cardiac rehabilitation (CR) for patients with heart failure with reduced ejection fraction was expanded in 2014, but contemporary referral and participation rates remain unknown.
METHODS
Patients hospitalized for heart failure with reduced ejection fraction (≤35%) in the American Heart Association Get With The Guidelines-Heart Failure registry from 2010 to 2020 were included, and CR referral status was described as yes, no, or not captured. Temporal trends in CR referral were assessed in the overall cohort. Patient and hospital-level predictors of CR referral were assessed using multivariable-adjusted logistic regression models. Additionally, CR referral and proportional utilization of CR within 1-year of referral were evaluated among patients aged >65 years with available Medicare administrative claims data who were clinically stable for 6-weeks postdischarge. Finally, the association of CR referral with the risk of 1-year death and readmission was evaluated using multivariable-adjusted Cox models.
RESULTS
Of 69,441 patients with heart failure with reduced ejection fraction who were eligible for CR (median age 67 years; 33% women; 30% Black), 17,076 (24.6%) were referred to CR, and referral rates increased from 8.1% in 2010 to 24.1% in 2020 (
CONCLUSIONS
CR referral rates have increased from 2010 to 2020. However, only 1 in 4 patients are referred to CR. Among eligible patients who received CR referral, participation was low, with <1 of 20 participating in CR.

Identifiants

pubmed: 37431671
doi: 10.1161/CIRCHEARTFAILURE.122.010144
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e010144

Subventions

Organisme : NHLBI NIH HHS
ID : T32 HL125247
Pays : United States
Organisme : NHLBI NIH HHS
ID : R38 HL150214
Pays : United States

Auteurs

Neil Keshvani (N)

Division of Cardiology, Department of Medicine, UT Southwestern Medical Center, Dallas, TX (N.K., V.S., A.P.).
Parkland Health and Hospital System, Dallas, TX (N.K., V.S., A.P.).

Vinayak Subramanian (V)

Division of Cardiology, Department of Medicine, UT Southwestern Medical Center, Dallas, TX (N.K., V.S., A.P.).
Parkland Health and Hospital System, Dallas, TX (N.K., V.S., A.P.).

Christopher A Wrobel (CA)

Division of Cardiology, Duke University Medical Center, Durham, NC (C.A.W., S.J.G., A.D.D.).

Nicole Solomon (N)

Duke Clinical Research Institute, Durham, NC (N.S., B.A., S.J.G., A.D.D.).

Brooke Alhanti (B)

Duke Clinical Research Institute, Durham, NC (N.S., B.A., S.J.G., A.D.D.).

Stephen J Greene (SJ)

Division of Cardiology, Duke University Medical Center, Durham, NC (C.A.W., S.J.G., A.D.D.).
Duke Clinical Research Institute, Durham, NC (N.S., B.A., S.J.G., A.D.D.).

Adam D DeVore (AD)

Division of Cardiology, Duke University Medical Center, Durham, NC (C.A.W., S.J.G., A.D.D.).
Duke Clinical Research Institute, Durham, NC (N.S., B.A., S.J.G., A.D.D.).

Clyde W Yancy (CW)

Division of Cardiology, Feinberg School of Medicine, Northwestern University, Chicago, IL (C.W.Y.).

Larry A Allen (LA)

Division of Cardiology, University of Colorado Medical Center, Aurora (L.A.A.).

Gregg C Fonarow (GC)

Ronald Reagan-UCLA Medical Center, Los Angeles, CA (G.C.F.).

Ambarish Pandey (A)

Division of Cardiology, Department of Medicine, UT Southwestern Medical Center, Dallas, TX (N.K., V.S., A.P.).
Parkland Health and Hospital System, Dallas, TX (N.K., V.S., A.P.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH